Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
A muscle enzyme; elevated levels indicate muscle damage or excessive exertion. Creatine kinase (CK) is measured by blood test as part of the Organ panel in the HodieLabs Health Blueprint.
Useful in performance users. Interpret using the reporting lab’s reference interval and clinical context; trend over time is often more informative than a single value.
Associated risks when out of range: Elevated CK indicates muscle damage, from exercise, rhabdomyolysis, myopathy, or cardiac events. Very high CK (>10× upper limit) with dark urine suggests rhabdomyolysis requiring urgent management.
The HodieLabs Evidence-Based Clinical Library classifies Creatine kinase (CK) as an strong evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is RCPA Australian pathology reference intervals; CK 30–200 U/L (male) / 25–170 U/L (female). Exercise-adjusted: recent vigorous exercise can transiently elevate CK. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets Creatine kinase (CK) against published clinical authority standards, never arbitrary "optimal" ranges. Measured in U/L:
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Creatine kinase (CK) is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. RCPA Australian pathology reference intervals; CK 30–200 U/L (male) / 25–170 U/L (female). Exercise-adjusted: recent vigorous exercise can transiently elevate CK.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
A muscle enzyme; elevated levels indicate muscle damage or excessive exertion.
The HodieLabs Evidence-Based Clinical Library optimal range is Male: 30–200; Female: 25–170 U/L, based on RCPA Australian pathology reference intervals; CK 30–200 U/L (male) / 25–170 U/L (female). Exercise-adjusted: recent vigorous exercise can transiently elevate CK.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: adjust training load, clinical review if very high. Interpretation and an action plan should always involve your doctor.
Creatine kinase (CK) is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Creatine kinase (CK) and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.